COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk A/S - Share repurchase programme

17/09/2018 - 14:29

Bagsværd, Denmark, 17 September 2018 - On 10 August 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

Avivagen Announces Approval from TSX Venture Exchange for Extension of Warrants

17/09/2018 - 14:26

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. OTTAWA, Sept. 17, 2018 (GLOBE NEWSWIRE) -- [...]

Tabula Rasa HealthCare’s Newly Acquired Subsidiary, Mediture, Expands Managed Long-term Care Services with Visiting Nurse Service of New York

17/09/2018 - 14:21

MOORESTOWN, N.J., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC) , a healthcare technology company advancing the field of medication safety, today announced its subsidiary, [...]

Apotheca Biosciences (PCFP) Overviews Pain-Patch, an Opioid Substitution

17/09/2018 - 14:02

Saint Petersburg, FL, Sept. 17, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Apotheca Biosciences (OTC PINK: PCFP), a developer of cutting-edge medical products, nutraceuticals, drug formulations and cannabis delivery [...]

VBL Therapeutics to Present at Upcoming Conferences in October

17/09/2018 - 14:00

TEL AVIV, Israel, Sept. 17, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]

Eidos Therapeutics Presents Data from its Phase 1 Clinical Trial of AG10 at the 22nd Annual Scientific Meeting of the Heart Failure Society of America

17/09/2018 - 14:00

SAN FRANCISCO, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Eidos Therapeutics , Inc. (Eidos) (Nasdaq:EIDX) announced the presentation of results from its Phase 1 clinical trial of AG10 during a poster session at the 22 nd Annual [...]

Spring Bank Pharmaceuticals, Inc. to Present at the 2018 Cantor Global Healthcare Conference

17/09/2018 - 14:00

HOPKINTON, Mass., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]

Retrotope Announces the Initiation of Expanded Access (Compassionate Use) Trial of RT001 in Amyotrophic Lateral Sclerosis (ALS)

17/09/2018 - 14:00

First ALS patient dosed with RT001 LOS ALTOS, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Retrotope today announced that it has supplied its drug RT001 for the initiation of an expanded access (EA) trial to treat [...]

Coherus BioSciences Management to Present at the 2018 Cantor Global Healthcare Conference in October

17/09/2018 - 14:00

REDWOOD CITY, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that senior management will be presenting at the 2018 Cantor Global Healthcare Conference being held in [...]

Conformis Announces Settlement of Patent Dispute with Smith & Nephew

17/09/2018 - 14:00

Conformis to Receive $10.5 Million for Non-Exclusive License to Patient-Specific Instrument Patents for use with off-the-shelf knee implants BILLERICA, Mass., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: [...]

CRISPR Therapeutics and ViaCyte Announce Strategic Collaboration to Develop Gene-Edited Stem Cell-Derived Therapy for Diabetes

17/09/2018 - 14:00

- Aims to develop an immune-evasive stem cell therapy as a potentially curative treatment for diabetes - - Parties will collaborate through commercialization and share costs and profits worldwide - ZUG, Switzerland and [...]

Aeglea BioTherapeutics Announces Oral Presentation of Preclinical Data on New Pipeline Therapeutic for Cystinuria at 2018 American Society of Nephrology

17/09/2018 - 14:00

AUSTIN, Texas, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare [...]

Pivotal Phase 3 Data from CONVERT Study of ALIS in Patients with Treatment-Refractory NTM Lung Disease Caused by MAC Published in American Journal of Respiratory and Critical Care Medicine

17/09/2018 - 14:00

--As previously reported, study met primary endpoint of culture conversion (p<0.0001)-- --ALIS under FDA Priority Review with PDUFA action date of September 28, 2018-- BRIDGEWATER, N.J., Sept. 17, 2018 (GLOBE [...]

Aphios Pharma LLC Announces Reg. CF Private Placement Offering

17/09/2018 - 14:00

WOBURN, Mass., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Aphios ® Pharma LLC is pleased to announce the launch of a private placement offering in accordance with Regulation Crowdfunding (Reg. CF) adopted by the U.S. Securities [...]

Greg Matz Joins Daré Bioscience Board of Directors

17/09/2018 - 14:00

SAN DIEGO, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today announced the appointment of Greg Matz to its board of directors. Most [...]

Soleno Therapeutics to Present DCCR Clinical Data at Late Breaking Sessions of the European Society for Paediatric Endocrinology

17/09/2018 - 14:00

REDWOOD CITY, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases will present [...]

Scythian Biosciences Announces Successful Results of Special Meeting of Shareholders

17/09/2018 - 14:00

Shareholders Approve Strategic Sale of Latin American Assets to Aphria in Exchange for 15,678,310 shares of Aphria (TSX:APH) Shareholders Approve Name Change to SOL Investments Corp. Scythian’s Issued and Outstanding [...]

InspireMD Announces Issuance of Two New U.S. Patents Covering Proprietary MicroNet™ Stent Jacket and Related Drug Eluting Technology

17/09/2018 - 14:00

Patents further strengthen intellectual property surrounding Company’s lead commercial product, CGuard™ EPS InspireMD remains on track to submit an Investigational Device Exception (IDE) with FDA in mid-2019 TEL AVIV, [...]

CareDx broadens HeartCare availability

17/09/2018 - 14:00

Launches HeartCare registry to increase patient access to comprehensive surveillance solution of AlloMap and AlloSure Heart BRISBANE, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular [...]